Is immunological recovery clinically relevant at 100 days after allogeneic transplantation?
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Jin | - |
dc.contributor.author | Lim, Sung Hee | - |
dc.contributor.author | Kim, Se Hyung | - |
dc.contributor.author | Yun, Jina | - |
dc.contributor.author | Kim, Chan Kyu | - |
dc.contributor.author | Lee, Sang Cheol | - |
dc.contributor.author | Won, Jong Ho | - |
dc.contributor.author | Hong, Dae Sik | - |
dc.contributor.author | Park, Seong Kyu | - |
dc.date.accessioned | 2021-08-11T08:34:22Z | - |
dc.date.available | 2021-08-11T08:34:22Z | - |
dc.date.issued | 2020-07 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.issn | 2005-6648 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/2684 | - |
dc.description.abstract | Background/Aims: Immune reconstitution following allogeneic hematopoietic stem cell transplantation (HSCT) is affected by multiple variables during the transplantation. Methods: We assessed the clinical factors contributing to immune function reconstitution at 100 days post-allogeneic HSCT in 114 patients receiving fludarabine-based conditioning. Immunophenotypic analysis using flow cytometry was performed to evaluate the percentage and the absolute numbers of T-cell subsets, natural killer cells, and B-cells as clinical outcomes. Results: Tacrolimus-based graft-versus-host disease (GVHD) prophylaxis, T-cell depletion, and acute GVHD were significantly associated with delayed immune reconstitution of T-cell subsets. The incidence of chronic GVHD was significantly increased in the normal recovery group compared to the abnormal group (p = 0.01). Epstein-Barr virus reactivation was more frequently observed in the abnormal group of T-cell subsets (p = 0.045). All viral reactivation events including cytomegalovirus reactivation appeared to be more frequent in the abnormal group of T-cell subsets. Conclusions: The immune recovery status post-allogeneic HSCT was affected by GVHD prophylactic regimens, especially in cases receiving tacrolimus-based GVHD prophylaxis, T-cell depletion, and possibly those manifesting acute GVHD. Delayed immune reconstitution might increase the morbidity due to viral reactivation. Treatment strategies are needed to prevent infectious complications and enhance immune reconstitution based on the immune recovery status following allogeneic HSCT with fludarabine-based conditioning. | - |
dc.format.extent | 13 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | 대한내과학회 | - |
dc.title | Is immunological recovery clinically relevant at 100 days after allogeneic transplantation? | - |
dc.type | Article | - |
dc.publisher.location | 대한민국 | - |
dc.identifier.doi | 10.3904/kjim.2018.414 | - |
dc.identifier.scopusid | 2-s2.0-85088274102 | - |
dc.identifier.wosid | 000546357400025 | - |
dc.identifier.bibliographicCitation | The Korean Journal of Internal Medicine, v.35, no.4, pp 957 - 969 | - |
dc.citation.title | The Korean Journal of Internal Medicine | - |
dc.citation.volume | 35 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 957 | - |
dc.citation.endPage | 969 | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002603423 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | STEM-CELL TRANSPLANTATION | - |
dc.subject.keywordPlus | VERSUS-HOST-DISEASE | - |
dc.subject.keywordPlus | IMMUNE RECONSTITUTION | - |
dc.subject.keywordPlus | CD8(+) | - |
dc.subject.keywordPlus | INDEX | - |
dc.subject.keywordPlus | RISK | - |
dc.subject.keywordAuthor | Hematopoietic stem cell transplantation | - |
dc.subject.keywordAuthor | Immunity | - |
dc.subject.keywordAuthor | Treatment outcomes | - |
dc.subject.keywordAuthor | Graft vs host disease | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.